Financhill
Back

KalVista Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
70

KALV
KalVista Pharmaceuticals, Inc.

Last Price:
$19.91
Seasonality Move:
-0.88%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KALV is experiencing buying pressure, which is a positive indicator for future bullish movement.

KalVista Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 18.76 Buy
20-day SMA: 17.67 Buy
50-day SMA: 16.39 Buy
200-day SMA: 14.3 Buy
8-day EMA: 18.94 Buy
20-day EMA: 17.87 Buy
50-day EMA: 16.76 Buy
200-day EMA: 14.61 Buy

KalVista Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.92 Buy
Relative Strength Index (14 RSI): 64.89 Buy
Chaikin Money Flow: 462350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.01 - 18.71) Buy
Bollinger Bands (100): (14.03 - 17.29) Buy

KalVista Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for KalVista Pharmaceuticals, Inc. Stock

Is KalVista Pharmaceuticals, Inc. Stock a Buy?

KALV Technical Analysis vs Fundamental Analysis

Buy
70
KalVista Pharmaceuticals, Inc. (KALV) is a Buy

Is KalVista Pharmaceuticals, Inc. a Buy or a Sell?

KalVista Pharmaceuticals, Inc. Stock Info

Market Cap:
1B
Price in USD:
19.90
Share Volume:
910.2K

KalVista Pharmaceuticals, Inc. 52-Week Range

52-Week High:
21.31
52-Week Low:
9.24
Buy
70
KalVista Pharmaceuticals, Inc. (KALV) is a Buy

KalVista Pharmaceuticals, Inc. Share Price Forecast

Is KalVista Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of KalVista Pharmaceuticals, Inc.

Is KalVista Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.90 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.83 per share, and an increase next year of $2.01 per share.

Technical Analysis of KalVista Pharmaceuticals, Inc.

Should I short KalVista Pharmaceuticals, Inc. stock?

* KalVista Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.